导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.48% | 298/904 |
| 近一周 | 0.01% | 758/949 |
| 近一月 | 0.09% | 92/938 |
| 近一季 | 0.32% | 608/934 |
| 近半年 | 0.70% | 255/918 |
| 近一年 | 1.59% | 307/901 |
| 近两年 | 3.74% | 722/801 |
| 近三年 | 5.90% | 627/678 |
| 成立以来 | 15.85% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.33% 108/917 |
0.49% 788/957 |
0.36% 77/973 |
- - |
| 2024 | 1.98% 782/908 |
0.47% 799/846 |
0.66% 699/862 |
0.15% 658/878 |
0.69% 773/908 |
| 2023 | 2.17% 664/832 |
0.64% 587/751 |
0.62% 687/771 |
0.37% 671/802 |
0.53% 754/832 |
| 2022 | 1.63% 400/729 |
0.52% 379/525 |
0.54% 466/610 |
0.45% 535/652 |
0.11% 260/729 |
| 2021 | 2.95% 222/489 |
0.85% 101/330 |
0.67% 228/361 |
0.77% 216/413 |
0.63% 320/489 |
| 2020 | 2.57% 125/351 |
0.86% 207/251 |
0.45% 53/292 |
0.60% 69/302 |
0.63% 191/329 |
| 2019 | - - |
- - |
- - |
0.71% 150/207 |
0.94% 51/237 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 中泰蓝月短债C VS. () |